Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.8100+0.0100 (+0.56%)
At close: 4:00PM EDT
1.8200 +0.01 (+0.55%)
After hours: 05:44PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close1.8000
Open1.7900
Bid1.8100 x 1100
Ask1.8200 x 2900
Day's Range1.7700 - 1.8200
52 Week Range1.6500 - 3.0600
Volume318,978
Avg. Volume366,003
Market Cap86.606M
Beta (5Y Monthly)-0.82
PE Ratio (TTM)N/A
EPS (TTM)-0.4550
Earnings DateNov 11, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AIM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AIM ImmunoTech Inc.
    Daily Spotlight: Another Reduction to Argus' 3Q GDP ForecastData that has emerged in recent weeks illustrates that the economy is still expanding, though some white-hot growth rates in certain sectors are starting to cool. The primary driver of GDP over the next few quarters is likely to be the country's physical health, as the nation recovers from the COVID-19 pandemic. Trends here have been slightly more positive in recent weeks, as the fourth wave of the pandemic, due largely to the Delta variant of COVID-19, may be past its peak. The domestic employment environment is in better shape than it was a year ago, though still far from full strength -- and it has weakened recently due to the Delta variant. Auto sales have recovered, but inventories are low due to bottlenecks. And the housing market, which had been strong in 1H21, is starting to cool as house prices soar. Rolling all the data up, and taking into account rising COVID cases as well as emerging supply chain issues and inventory levels, our GDP model now calls for 4.2% increase in GDP in 3Q21. We expect better growth in 4Q, too, before rates fall somewhat more sharply in 2022. On an annual basis, we look for overall GDP growth of approximately 5.8% in 2021 and 3.7% in 2022. Our estimates are consistent with consensus forecasts and the outlook from the Federal Reserve, which call for growth of 4%-6% in 2021. The GDPNow Forecast from the Federal Reserve Bank of Atlanta is 3.2% for 3Q21.
    Rating
    Fair Value
    Economic Moat
    22 days agoArgus Research
View more
Advertisement
Advertisement